CompanyGraph
What stands out
- Pays more per share than it earned over the last twelve months
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleRevenue is $31.03M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 10.87: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
What stands out
- Pays more per share than it earned over the last twelve months
Dividends view
Yield
0.51%
Annual Rate
CNY 0.14Paid annual
Payout Ratio
186.6%High
Last Ex-Dividend
Jun 1, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
2.07BCNY308.42M · vs all stocks (USD)
Trailing P/E
337.75xRevenue (TTM)
207.96MCNY31.03M · vs all stocks (USD)
Profit Margin
2.83%Beta
0.5170xvs all stocks
52-Week Change
-5.45%vs all stocks
Market Capitalization
2.07BCNY308.42M · vs all stocks (USD)
Enterprise Value
1.89BCNY281.35M · vs all stocks (USD)
Trailing P/E
337.75xPrice to Sales (TTM)
9.94xPrice to Book (MRQ)
2.34xEnterprise to Revenue
9.07xEnterprise to EBITDA
50.83xGross Margin
75.53%Profit Margin
2.83%Operating Margin
-8.97%Return on Assets (TTM)
-0.23%Return on Equity (TTM)
0.46%Revenue (TTM)
207.96MCNY31.03M · vs all stocks (USD)
Revenue per Share (TTM)
2.73CNYUpdated Sep 21, 2026Quarterly Revenue Growth
-40.20%Gross Profit (TTM)
152.70MCNY22.79M · vs all stocks (USD)
EBITDA (TTM)
56.78MCNY8.47M · vs all stocks (USD)
Net Income (TTM)
5.88MCNY877.81K · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-12.86%Operating Cash Flow (TTM)
42.62MCNY6.36M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
-2.48MCNY-369.48K · vs all stocks (USD)
Trailing Annual Dividend Rate
0.1450CNYUpdated Sep 21, 2026Trailing Annual Dividend Yield
0.51%vs all stocks
Payout Ratio
186.62%Minority Interest (Equity)
30.51MCNYFY2025 · Dec 31, 2025Revenue
234.84MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
55.74MCNYFY2025 · Dec 31, 2025Gross Profit
179.10MCNYFY2025 · Dec 31, 2025Operating Income
17.14MCNY2.56M · vs all stocks (USD)
Pre-tax Income
21.00MCNYFY2025 · Dec 31, 2025Income Tax Expense
1.10MCNYFY2025 · Dec 31, 2025Net Income
19.90MCNYFY2025 · Dec 31, 2025EBIT
21.44MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
56.78MCNYFY2025 · Dec 31, 2025Research & Development
11.25MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
109.49MCNYFY2025 · Dec 31, 2025Other Operating Expenses
7.54MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
450.02KCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
444.83KCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2863CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2863CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
76.49MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
76.49MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
19.90MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
2.00MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
18.24MCNYFY2025 · Dec 31, 2025Free Cash Flow
-47.82MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
28.95MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
19.90MCNYFY2025 · Dec 31, 2025Other Non-cash Items
523.00KCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
1.25MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-3.43MCNYFY2025 · Dec 31, 2025Capital Expenditures
-66.06MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.08BCNYFY2025 · Dec 31, 2025Sale of Investments
956.78MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-185.64MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
11.53MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-10.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-20.32MCNYFY2025 · Dec 31, 2025Other Financing Charges
-5.36MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-24.15MCNYFY2025 · Dec 31, 2025Shares Outstanding
76.49MSharesUpdated Sep 21, 2026Float Shares
39.58MSharesUpdated Sep 21, 2026% Held by Insiders
50.58%vs all stocks
% Held by Institutions
12.26%vs all stocks
Total Cash (MRQ)
223.80MCNY33.40M · vs all stocks (USD)
Total Cash per Share (MRQ)
2.96CNYUpdated Sep 21, 2026Total Debt (MRQ)
39.98MCNY5.97M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0444xCurrent Ratio (MRQ)
3.33xBook Value per Share (MRQ)
11.54CNYUpdated Sep 21, 2026Total Assets
1.06BCNY158.41M · vs all stocks (USD)
Total Current Assets
342.86MCNYFY2025 · Dec 31, 2025Total Liabilities
126.80MCNYFY2025 · Dec 31, 2025Total Non-current Assets
718.72MCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
38.38MCNYFY2025 · Dec 31, 2025Total Current Liabilities
88.42MCNYFY2025 · Dec 31, 2025Cash
28.94MCNYFY2025 · Dec 31, 2025Cash Equivalents
565.59KCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
29.51MCNYFY2025 · Dec 31, 2025Other Short-term Investments
206.95MCNYFY2025 · Dec 31, 2025Accounts Receivable
32.92MCNYFY2025 · Dec 31, 2025Inventory
28.19MCNYFY2025 · Dec 31, 2025Accounts Payable
48.84MCNYFY2025 · Dec 31, 2025Short-term Debt
11.61MCNYFY2025 · Dec 31, 2025Other Current Liabilities
390.75KCNYFY2025 · Dec 31, 2025Common Stock (Book)
76.49MCNYFY2025 · Dec 31, 2025Retained Earnings
391.07MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
934.78MCNY139.49M · vs all stocks (USD)
52-Week Low
21.88CNYUpdated Sep 21, 202652-Week High
39.98CNYUpdated Sep 21, 202652-Week Change
-5.45%vs all stocks
Beta
0.5170xvs all stocks
50-Day MA
27.16CNYUpdated Sep 21, 2026200-Day MA
29.19CNYUpdated Sep 21, 2026Avg 10-Day Volume
4.65MSharesUpdated Sep 21, 2026Avg 30-Day Volume
8.73MSharesUpdated Sep 21, 2026Diluted EPS (TTM)
0.0800CNYUpdated Sep 21, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Pays more per share than it earned over the last twelve monthsSignificant
Payout Ratio: 1.87Dividend per Share: 0.14Earnings per Share: 0.08
High gross margins eroded by operating costsNotable
Gross Margin: 0.76Profit Margin: 0.03
Financial Health
Altman Z-Score 10.87: safe zoneNotable
Altman Z-Score: 10.87
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Revenue is $31.03M, lower than 95% of all stocks globallySignificant
Revenue (USD): 31,031,179.995Global P5: 33,357,653.812
Companies that share the same coordination system — how they create, deliver, or capture value.
Evommune, Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Abeona Therapeutics Inc.
Tier 1ProductionApproval-Gated PipelineRule
Animalcare Group Plc
Tier 1ProductionApproval-Gated PipelineRuleFlow
AtaiBeckley Inc.
Tier 1ProductionApproval-Gated PipelineRule
Aprilbio Co. Ltd.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Lavipharm S.A.
Tier 1ProductionApproval-Gated PipelineRuleFlow
CytoDyn Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Guiyang Xintian Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Vanda Pharmaceuticals Inc.
Tier 1ProductionApproval-Gated PipelineRule
Essex Bio-Technology Ltd.
Tier 1ProductionApproval-Gated PipelineRule